Mesothelin and MUC16 (CA125) Are Antigen-Targets for CAR T-Cell Therapy in Primary and Metastatic Lung Adenocarcinoma

被引：0
|
作者：
Eguchi, Takashi [1 ]
Ujiie, Hideki [1 ]
Morello, Aurore [2 ,3 ]
Kadota, Kyuichi [4 ]
Buitrago, Daniel H. [1 ]
Woo, Kaitlin [5 ]
Jones, David R. [1 ]
Travis, William D. [6 ]
Sadelain, Michel [3 ]
Adusumilli, Prasad S. [2 ,3 ]
机构：
[1] Mem Sloan Kettering Canc, Dept Surg, Thorac Serv, New York, NY USA
[2] Mem Sloan Kettering Canc, Thorac Serv, New York, NY USA
[3] Mem Sloan Kettering Canc, Ctr Cell Engn, New York, NY USA
[4] Kagawa Univ, Dept Diagnost Pathol, Takamatsu, Kagawa 760, Japan
[5] Mem Sloan Kettering Canc, Dept Epidemiol & Biostat, New York, NY USA
[6] Mem Sloan Kettering Canc, Dept Pathol, New York, NY USA
来源：
JOURNAL OF THORACIC ONCOLOGY | 2015年 / 10卷 / 09期
关键词：
MUC16; mesothelin; Immunotherapy;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
ORAL28.05
引用
收藏
页码：S229 / S229
页数：1
相关论文
共 50 条
  • [21] Immune cell bound MUC16 (CA125): A novel diagnostic marker for ovarian cancer
    Belisle, Jennifer A.
    Felder, Mildred
    Kapur, Arvinder
    Tyler, Chanel T.
    Connor, Joseph P.
    Patankar, Manish S.
    CANCER RESEARCH, 2011, 71
  • [22] MUC16 (CA125) regulates epithelial ovarian cancer cell growth, tumorigenesis and metastasis
    Theriault, Catherine
    Pinard, Maxime
    Comamala, Marina
    Migneault, Martine
    Beaudin, Julie
    Matte, Isabelle
    Boivin, Marianne
    Piche, Alain
    Rancourt, Claudine
    GYNECOLOGIC ONCOLOGY, 2011, 121 (03) : 434 - 443
  • [23] Novel mesothelin-based CAR T cells targeting MUC16 as an intravesical bladder cancer therapy
    Abrahimi, Parwiz
    Khan, Jonathan
    Brentjens, Renier
    Merghoub, Taha
    Wolchok, Jedd
    CLINICAL CANCER RESEARCH, 2024, 30 (10)
  • [24] Solution structure of the SEA domain from the murine homologue of ovarian cancer antigen CA125 (MUC16)
    Maeda, T
    Inoue, M
    Koshiba, S
    Yabuki, T
    Aoki, M
    Nunokawa, E
    Seki, E
    Matsuda, T
    Motoda, Y
    Kobayashi, A
    Hiroyasu, F
    Shirouzu, M
    Terada, T
    Hayami, N
    Ishizuka, Y
    Shinya, N
    Tatsuguchi, A
    Yoshida, M
    Hirota, H
    Matsuo, Y
    Tani, K
    Arakawa, T
    Carninci, P
    Kawai, J
    Hayashizaki, Y
    Kigawa, T
    Yokoyama, S
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2004, 279 (13) : 13174 - 13182
  • [25] Co-expression of mesothelin and CA125/MUC16 is a prognostic factor for breast cancer, especially in luminal-type breast cancer patients
    Takahiro Einama
    Yoji Yamagishi
    Yasuhiro Takihata
    Takafumi Suzuki
    Tamio Yamasaki
    Yuichi Hirose
    Kazuki Kobayashi
    Naoto Yonamine
    Ibuki Fujinuma
    Takazumi Tsunenari
    Makiko Koga
    Yusuke Ishibashi
    Ken Nagata
    Takehiro Shiraishi
    Akiko Nakazawa
    Toshimitsu Iwasaki
    Eiji Shinto
    Kimi Kato
    Kimiya Sato
    Hideki Ueno
    Yoji Kishi
    Hitoshi Tsuda
    Biomarker Research, 9
  • [26] Co-expression of mesothelin and CA125/MUC16 is a prognostic factor for breast cancer, especially in luminal-type breast cancer patients
    Einama, Takahiro
    Yamagishi, Yoji
    Takihata, Yasuhiro
    Suzuki, Takafumi
    Yamasaki, Tamio
    Hirose, Yuichi
    Kobayashi, Kazuki
    Yonamine, Naoto
    Fujinuma, Ibuki
    Tsunenari, Takazumi
    Koga, Makiko
    Ishibashi, Yusuke
    Nagata, Ken
    Shiraishi, Takehiro
    Nakazawa, Akiko
    Iwasaki, Toshimitsu
    Shinto, Eiji
    Kato, Kimi
    Sato, Kimiya
    Ueno, Hideki
    Kishi, Yoji
    Tsuda, Hitoshi
    BIOMARKER RESEARCH, 2021, 9 (01)
  • [27] Immunocytokine KS-IL2 overcomes MUC16/CA125 steric barrier to NK cell lysis
    Arens-Gubbels, J.
    Patankar, M.
    Felder, M.
    Connor, J.
    GYNECOLOGIC ONCOLOGY, 2008, 111 (02) : 376 - 377
  • [28] CA125 (MUC16) tumor antigen selectively modulates the sensitivity of ovarian cancer cells to genotoxic drug-induced apoptosis
    Boivin, Marianne
    Lane, Denis
    Piche, Alain
    Rancourt, Claudine
    GYNECOLOGIC ONCOLOGY, 2009, 115 (03) : 407 - 413
  • [29] Cell Surface Bound MUC16 (CA125) Shields Ovarian Tumor Cells From Natural Killer Cell Mediated Attack
    Gubbels, Jennifer A.
    Felder, Mildred
    Belisle, Jennifer A.
    Holden, Helen
    Petrie, Sarah
    Migneault, Martine
    Rancourt, Claudine
    Connor, Joseph
    Patankar, Manish S.
    JOURNAL OF IMMUNOTHERAPY, 2008, 31 (09) : 964 - 964
  • [30] Transformation of NIH3T3 mouse fibroblast cells by MUC16 mucin (CA125) is driven by its cytoplasmic tail
    Giannakouros, Panagiota
    Matte, Isabelle
    Rancourt, Claudine
    Piche, Alain
    INTERNATIONAL JOURNAL OF ONCOLOGY, 2015, 46 (01) : 91 - 98
12345